2型糖尿病和甲胺对阿尔茨海默病的相反因果作用
Dongming Liu1, Hongbao Cao2, Ancha Baranova3
1Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Zhongshan Road, Nanjing, 210008, PR China; Department of Neurosurgery, the Affiliated Brain Hospital of Nanjing Medical University, Guangzhou Road, Nanjing, Jiangsu, 210029, PR China.
The journal of prevention of Alzheimer's disease
|March 10, 2025
概括
2型糖尿病 (T2D) 不会增加阿尔茨海默病 (AD) 的风险. 然而,抗糖尿病药物甲福明可能会增加AD风险,突出显示T2D患者需要谨慎处方.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2D) 经常与阿尔茨海默氏症 (AD) 一起发生.
- 对于T2D及其常见治疗方法甲胺对AD进展的独立贡献尚不清楚.
研究的目的:
- 调查T2D和甲福林使用对AD发展风险的整体和独立因果关系.
主要方法:
- 使用总结全基因组关联研究数据集进行门德尔随机化 (MR) 和多变量MR (MVMR) 分析.
- 包括T2D,甲福林和AD的大规模数据集.
- 在FDA不良事件报告系统 (FAERS) 数据库中分析了AD相关的不良药物事件.
主要成果:
- 两个样本的MR显示T2D和AD风险之间没有关联.
- 甲胺暴露显示了增加AD风险的趋势 (P=0.053).
- MVMR显示T2D独立降低了AD风险 (OR=0.82,P=0.031),而甲素独立增加了AD风险 (OR=1.26,P=9.45E-3).
结论:
- 暴露于T2D和甲胺对AD风险产生了相反的独立因果作用.
- 在给T2D患者开甲福林时,评估AD风险至关重要.
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
21
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21
Oral Hypoglycemic Agents: Biguanides and Glitazones
149
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
149
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Alzheimer's Disease: Treatment
142
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
142


